Phathom Pharmaceuticals, Inc. (PHAT) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello, and welcome to the Fathom Pharmaceuticals first quarter 2025 earnings results call. At this time, all participants are in a listen-only mode. After the presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1 1 again. Please be advised that today's conference is being recorded. With that, I would like to turn the conference over to Eric Chiarelli, Fathom's Head of Investor Relations. Please go ahead. Thank you, Operator. Hello, everyone, and thank you for joining us this morning to discuss Fathom's first quarter 2025 results. This morning's presentation will include remarks from Steve Basta, our President and CEO, and Molly Henderson, our Chief Financial and Business Officer. Robert Breedlove, our VP of Finance and Principal Accounting Officer, will also be joining the team during the Q&A portion of today's call. Just a couple of logistical items before we get started. Earlier this morning, we issued a press release detailing the results we will be discussing during the call. A copy of that press release can be found under the news releases section of our corporate website. Further, the recording of today's webcast can be found under the events and presentation section of our corporate website. Before we begin, let me remind you that we will be making a number of forward-looking statements throughout today's presentation. These forward-looking statements involve risks and uncertainties, many of which are beyond Fathom's control. Actual results can materially differ from the forward-looking statements, and any such risks can materially adversely affect the ...